Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
16.46
-0.46 (-2.72%)
At close: Apr 28, 2026, 4:00 PM EDT
16.42
-0.04 (-0.24%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $1.17 billion as of April 28, 2026. Its market cap has increased by 110.00% in one year.
Market Cap
1.17B
Enterprise Value
1.11B
1-Year Change
110.00%
Ranking
Category
Stock Price
$16.46
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $1.17B, an increase of 809.44%. That is a compound annual growth rate of 8.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.30B |
| Novavax | 1.30B |
| AbCellera Biologics | 1.26B |
| DBV Technologies | 1.22B |
| MoonLake Immunotherapeutics | 1.21B |
| GH Research | 1.19B |
| UroGen Pharma | 1.16B |
| EyePoint | 1.13B |